Lia Gore is a Professor with Tenure in the Departments of Pediatrics, Medical Oncology, and Hematology at the University of Colorado School of Medicine, where she also serves as Chief of Pediatric Hematology/Oncology/BMT-Cellular Therapeutics. At the Children’s Hospital Colorado, Dr. Gore holds the Ergen Family Chair in Pediatric Oncology.
Additionally, Dr. Gore is Co-Director of the Developmental Therapeutics (Phase I clinical trials) Program at the University of Colorado Comprehensive Cancer Center and is the current Groupwide Vice Chair in the National Cancer institute-sponsored Children’s Oncology Group. Dr. Gore’s primary interests are in drug development for refractory cancers and treatment of leukemias. She has received funding from the National Cancer Institute, the Leukemia and Lymphoma Society, Alex’s Lemonade Stand, and numerous foundation awards. Dr. Gore has authored more than 100 peer-reviewed publications, has lectured broadly both in the United States and internationally and has advised the U.S. FDA and European Medicines Agency.
Dr. Gore received her medical degree at the George Washington University School of Medicine. She did her internship in Pediatrics at Children’s National Medical in Washington, DC, and residency in Pediatrics at Children’s Colorado. She then had a fellowship in Pediatric Hematology, Oncology, Bone Marrow Transplant, and was a postdoctoral research fellow in Immunology and Hematopoiesis at National Jewish Medical and Research Center and in Leukemia Biology at Children’s Colorado and the University of Colorado.